Moving Beyond Minimization Trials in Kidney Transplantation
- PMID: 25925686
- PMCID: PMC4657847
- DOI: 10.1681/ASN.2015030245
Moving Beyond Minimization Trials in Kidney Transplantation
Keywords: drug minimization; immunosuppression; renal transplantation.
Comment on
-
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.J Am Soc Nephrol. 2015 Dec;26(12):3114-22. doi: 10.1681/ASN.2014121234. Epub 2015 Apr 29. J Am Soc Nephrol. 2015. PMID: 25925687 Free PMC article. Clinical Trial.
References
-
- Hricik DE, O’Toole MA, Schulak JA, Herson J: Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 4: 1300–1305, 1993 - PubMed
-
- Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, Ewell M, McIntosh M, Stablein D, Hodge E: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil – a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 68: 1865–1874, 1999 - PubMed
-
- Vanrenterghem Y, Lebranchu Y, Hené R, Oppenheimer F, Ekberg H: Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 70: 1352–1359, 2000 - PubMed
-
- Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P, Astellas Corticosteroid Withdrawal Study Group: A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 248: 564–577, 2008 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
